Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2020

May 27, 2020

32939_dirs_2020-05-27_187a743c-d86e-4af5-8c42-ba8fc0c28f8b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2020-05-23

Reporting Person: Campbell Chad Thomas (SVP/GM, Vascular Access)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-23 Common Stock F 826 $11.21 Disposed 18102 Direct

Footnotes

F1: This exempt disposition of 826 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016.